- ►ahajournals.org N Urao, M Okigaki, H Yamada, Y Aadachi, K … - Circulation research, 2006 - Am Heart Assoc We investigated whether the mobilization of endothelial progenitor cells (EPCs)
by exogenous erythropoietin (Epo) promotes the repair of injured endothelium.
Recombinant human Epo was injected (1000 IU/kg for the initial 3 days) ... Cited by 91 - Related articles - All 8 versions
- ►alphamedpress.org Y Wu, L Chen, PG Scott, EE Tredget - Stem Cells, 2007 - AlphaMed Press Although chronic wounds are common, treatment for these disabling conditions
remains limited and largely ineffective. In this study, we examined the benefit
of bone marrow-derived mesenchymal stem cells (BM-MSCs) in wound healing. ... Cited by 75 - Related articles - BL Direct - All 7 versions
- ►prsjournal.net MO Arcasoy - British journal of haematology, 2008 - pt.wkhealth.com In the haematopoietic system, the principal function of erythropoietin (Epo) is
the regulation of red blood cell production, mediated by its specific cell
surface receptor (EpoR). Following the cloning of the Epo gene (EPO) and ... Cited by 58 - Related articles - BL Direct - All 9 versions
S Schiekofer, G Galasso, K Sato, BJ Kraus, K … - Arteriosclerosis Thrombosis and Vascular Biology, 2005 - Am Heart Assoc Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams &
Wilkins, a division of Wolters ... Impaired Revascularization in a Mouse ... Cited by 41 - Related articles - All 8 versions
L Chen, EE Tredget, PYG Wu, Y Wu - PLoS One, 2008 - pubmedcentral.nih.gov Bone marrow derived mesenchymal stem cells (BM-MSCs) have been shown to enhance
wound healing; however, the mechanisms involved are barely understood. In this
study, we examined paracrine factors released by BM-MSCs and their effects ... Cited by 39 - Related articles - All 8 versions
- ►critcaremed.com M Galeano, D Altavilla, A Bitto, L Minutoli, M … - Critical care medicine, 2006 - journals.lww.com From the Department of Clinical and Experimental Medicine and Pharmacology (MG,
DA, AB, LM, FP, FS), Department of Surgical Sciences, Section of Plastic Surgery
(MG), Department of Veterinary Public Health (MC), Section of Veterinary ... Cited by 35 - Related articles - BL Direct - All 10 versions
P Katavetin, R Inagi, T Miyata, J Shao, R … - Biochemical and Biophysical Research …, 2007 - Elsevier Recent studies have established that erythropoietin (EPO) is a pleiotropic
cytokine. In this study we investigated whether pleiotropic effects of EPO may
involve regulation of heme oxygenase (HO)-1, an anti-oxidative stress ... Cited by 26 - Related articles - All 6 versions
H Sayan, VH Ozacmak, A Guven, RG Aktas, … - Investigative Surgery, 2006 - informahealthcare.com Erythropoietin exerts hematopoietic effects by stimulating proliferation of
early erythroid precursors. Nonhematopoietic effects of erythropoietin have also
been shown. It may act as a new angiogenic factor in wound healing. This ... Cited by 14 - Related articles - BL Direct - All 5 versions
- ►bentham.org [PDF] M Thomas, C Tsalamandris, R MacIsaac, G … - Current Diabetes Reviews, 2005 - ingentaconnect.com Abstract: Diabetes as the dominant cause of ESRD is also the major cause of
renal anaemia. However, most patients with diabetic kidney disease will succumb
to co-morbid vascular disease or heart failure before developing severe ... Cited by 15 - Related articles - BL Direct - All 5 versions
D Mocini, T Leone, M Tubaro, M Santini, M … - Current medicinal chemistry, 2007 - ingentaconnect.com Erythropoietin (EPO) is a glycoprotein produced mainly in the kidney [1]. EPO
binds to a specific membrane receptor, produces dimerization of the receptor and
subsequent activation of at least three downstream pathways associated with ... Cited by 10 - Related articles - BL Direct - All 3 versions
